Abbott falls after Q4 revenue misses estimates, downbeat Q1 profit forecast

Abbott Laboratories

22/01/2026 14:38

Updates

** Shares of medical device maker Abbott Laboratories ABT.N fall 10.5% to $107.43

** Co posts Q4 revenue of $11.46 billion, missing analysts' estimate of $11.8 billion, according to data compiled by LSEG

** ABT expects adjusted per-share profit of between $1.12 and $1.18 for the first quarter, below analysts' estimate of $1.20 per share

** Forecasts 2026 adj. profit in the range of $5.55 to $5.80 per share, compared with analysts' estimate of $5.68 per share

** "I continue to think this story is challenged, and now investors will have many more questions as to the timing and strategic rationale of the EXAS acquisition, which we never thought made a whole lot of sense," said Bernstein analyst Christian Moore

** Reports Q4 adj. profit of $1.50 per share, in line with estimates

** ABT stock climbed 10.7% in 2025

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))